Er-100: Human-Tested Glaucoma and Aging Treatment

invdes.com.mx

Factuality

Ownership

A team of researchers has begun clinical trials of the drug ER-100, a therapy designed to reprogram cells and restore vitality to damaged tissues. Medicine faces a paradigm shift in the fight against the passage of time. What formerly belonged to the field of scientific speculation is today a line of clinical research with specific deadlines. Experts now focus their attention on the root of physical wear to try to return cells to their own healt…

Numerama

Factuality

Ownership

The Biotech Life Biosciences is about to test its ER-100 experimental treatment on humans. Based on partial cellular reprogramming, this gene therapy aims to reverse the damage of the optic nerve. A major technological leap that revives the hope of biological "uptime", while raising crucial health challenges.